Kamada
KMDA | NASDAQ
$8.11
+$0.02 (+0.25%)
At close: Nov 16, 2026, 4:00 PM ET
$8.10
-$0.01 (-0.12%)
After-hours:
Nov 16, 2026, 7:55 PM ET
+0.25%
(1D)Rating
72
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #42/1021 (Top 4%)
Key Statistics
Market Data
Market Cap $467.8M
1D Range
8.08 8.25
52W Range
6.68 9.31
Valuation (TTM)
PE 18.86
PB 1.74
EV/EBITDA 8.85
Valuation (NTM)
Forward PE 16.85
Forward PEG 0.58
Price Target $15.00
Cash Flow
FCF Yield 7.6%
SBC Adj. FCF Yield 7.5%
SBC Impact -2.2%
Margins
Gross Margin 41.6%
Operating Margin 15.4%
FCF Margin 18.2%
Growth (CAGR)
Revenue 3Y | 5Y 8.9% |
13.6%
Dil EPS 3Y | 5Y 53.0% |
33.9%
FCF 3Y | 5Y 172.8% |
51.2%
Returns
ROA 6.5%
ROE 9.3%
ROIC 7.5%
Financial Health
Net Cash
$72.94M
Current Ratio 4.17
Interest Coverage 28.79
Dividends
Div Yield 2.10%
Payout Ratio 39.5%
FCF Payout Ratio 66.7%
Loading financial charts...
Profile
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its...
Sector Healthcare
Employees 462
IPO Date May 31, 2013
Website www.kamada.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 9, 2026
EPS
$0.14
Beat +9.80%
YoY:
+55.56% REV
$52.03M
Miss -0.90%
YoY:
+10.69%Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$15.00
Upside
+84.96%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove KMDA